The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.

BOULDER, Colo., Aug. 29, 2025 /PRNewswire/ -- Foresight Diagnostics ("Foresight") today announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche ...

Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The update significantly enhances the efficiency of laboratories by optimizing resources, reducing downtime, ...

Roche Molecular Systems, Inc. , doing business as Roche Molecular Diagnostics, awarded a $4.6 million contract to Johnson Controls, Inc. for building systems and services at the company's growing ...